Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437994

Medchemexpress LLC Almonertinib hydrochloride | 2134096-03-8 | 98.9% | 562.11 | 1 ML
SDP

Catalog No. 5000437994
Encompass_Preferred

Almonertinib hydrochloride is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. It shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19, and is less effective against wild type. Almonertinib hydrochloride is used for the research of non-small cell lung cancer. It can also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q.

  • Orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor.
  • High selectivity for EGFR-sensitizing and T790M resistance mutations.
  • Great inhibitory activity against T790M, T790M/L858R and T790M/Del19.
  • Less effective against wild-type EGFR.
  • Used for research of non-small cell lung cancer.
  • Inhibits other EGFR sensitive mutations such as G719X, del19, L858R and L861Q.

Catalog No. 50-004-37994 Supplier Medchemexpress LLC Supplier No. HY112823B10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Almonertinib hydrochloride is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. It shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19, and is less effective against wild type. Almonertinib hydrochloride is used for the research of non-small cell lung cancer. It can also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q.

  • Orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor.
  • High selectivity for EGFR-sensitizing and T790M resistance mutations.
  • Great inhibitory activity against T790M, T790M/L858R and T790M/Del19.
  • Less effective against wild-type EGFR.
  • Used for research of non-small cell lung cancer.
  • Inhibits other EGFR sensitive mutations such as G719X, del19, L858R and L861Q.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.